Is reimbursement for alerts and real-time continuous glucose monitoring needed?

[...]data from Visser and colleagues could be invaluable. [...]many quality-of-life aspects using CGM are not covered in current cost-efficacy analyses. [...]different interpretations of cost-efficacy analyses might arise across countries and continue to result in erratic reimbursement and frustrati...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2021-06, Vol.397 (10291), p.2230-2232
Main Authors: Nørgaard, Kirsten, Schmidt, Signe
Format: Article
Language:English
Subjects:
Blood Glucose
Blood Glucose Self-Monitoring
Cost analysis
Diabetes
Diabetes Mellitus, Type 1
Frustration
Glucose monitoring
Humans
Hypoglycemia
Insulin
Medical equipment
Reimbursement
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]data from Visser and colleagues could be invaluable. [...]many quality-of-life aspects using CGM are not covered in current cost-efficacy analyses. [...]different interpretations of cost-efficacy analyses might arise across countries and continue to result in erratic reimbursement and frustration. [...]Visser and colleagues should be commended for addressing an important clinical question regarding the efficacy of two different CGM systems.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(21)01211-3